Central Role For Industry Beckons As Europe Rebuilds After COVID

Generics And Biosimilars Must Become A Central Policy Pillar, Says Rebecca Guntern

 
• By David Wallace
  
EU Flag Brick Wall Exploded
Generics and biosimilars can help Europe to rebuild post-COVID • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin